Annual Report 2024

CONSOLIDATED STATEMENT OF CASH FLOWS For the year ended 31 December 2024 49 The United Laboratories International Holdings Limited Annual Report 2024 2024 2023 RMB’000 RMB’000 Operating activities Profit before taxation 3,288,898 3,344,148 Adjustments for: Write-down of inventories (reversed) recognised (15,959) 43,188 Reversal of write-down deposits for property, plant and equipment – (5,563) Impairment loss recognised (reversed) under expected credit loss model, net 44,880 (1,962) Amortisation of intangible assets 19,486 17,447 Depreciation of property, plant and equipment 579,883 536,303 Depreciation of right-of-use assets 16,178 11,898 Net (gain) loss on fair value changes of derivative financial instruments (92,032) 12,399 Gain on disposal of financial assets at fair value through profit or loss (66,501) (72,748) Finance costs 34,958 66,896 Release of government grants (14,886) (22,274) Bank interest income (127,791) (105,415) Share of results of an associate 192 (143) Share-based payment expense 47,364 6,365 Net loss on disposal of property, plant and equipment 4,269 3,703 Gain on termination of lease contracts (8) – Written off of property, plant and equipment 23,297 47,955 Net unrealised foreign exchange loss (gain) 74 (10,972) Operating cash flows before movements in working capital 3,742,302 3,871,225 Increase in inventories (179,723) (118,045) Decrease (increase) in trade and bills receivables, other receivables, deposits and prepayments 429,076 (1,562,217) (Decrease) increase in trade and other payables (115,148) 792,368 Decrease in contract liabilities (19,465) (16,901) Cash generated from operations 3,857,042 2,966,430 Income taxes paid (657,740) (526,992) Net cash from operating activities 3,199,302 2,439,438